Bristol-Myers Squibb Logo

Bristol Myers Squibb GC to Retire After 33 years With Drugmaker

Sandra Leung began her legal career prosecuting homicides, a formative experience that she once said taught her "to make decisions quickly and to be accountable for those decisions."

Seeking Alpha · 23h

Bristol-Myers Squibb Stock: A Strong Buy Amid Oncology Success

Bristol-Myers Squibb released financial results for Q4 2024. Check out why I am upgrading BMY stock's rating from 'Buy' to 'Strong Buy'.

Business Insider · 1d

Bristol-Myers Squibb (BMY) Gets a Hold from Bernstein

Bernstein analyst Courtney Breen maintained a Hold rating on Bristol-Myers Squibb (BMY – Research Report) yesterday and set a price target of

MarketWatch · 1d

Bristol Myers Squibb Co. stock outperforms competitors on strong trading day

Shares of Bristol Myers Squibb Co. BMY rose 1.47% to $55.79 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.43% to 6,117.

pharmaphorum2d

A history of Bristol-Myers Squibb

Around the same time, the prototype of the Squibb logo was designed. The logo represented product uniformity, purity, efficacy and reliability based on research. By 1924, Bristol-Myers' gross ...

Bristol Myers Squibb Names New GC as Legal Chief Retires

Bristol Myers Squibb Co. said Cari Gallman, the company’s executive vice president for corporate affairs, will become its ...

Bristol-Myers Squibb (BMY) Receives a Buy from Truist Financial

Truist Financial analyst Srikripa Devarakonda maintained a Buy rating on Bristol-Myers Squibb (BMY – Research Report) today. The company’s ...

MedCity News1mon

Bristol Myers Squibb

The new product will help Bristol Myers Squibb compete with biosimilars as Opdivo faces looming patent expiration. Sotyktu, which became the first TYK2 inhibitor to reach the market after its 2022 ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results